X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XFOR | LCTX | RCKT | ||
| Company | X4 Pharmaceuticals Inc | Lineage Cell Therapeutics Inc | Rocket Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 4.35 | 1.7300 | 3.53 | ||
| High | 4.35 | 1.7300 | 3.53 | ||
| Low | 4.35 | 1.7300 | 3.53 | ||
| Latest | 4.35 | 1.7300 | 3.53 | ||
| Change | -0.07 | +0.0500 | +0.02 | ||
| % Change | -1.58% | +2.98% | +0.57% | ||
| Volume | 679 | 100 | 10,025 | ||
| 20-Day Average Volume | 914,989 | 1,299,365 | 1,906,466 | ||
| Previous Close | 4.42 | 1.6800 | 3.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.77 | 1.7115 | 3.38 | ||
| 20-Day Raw Stochastic | 86.38% | 64.00% | 78.95% | ||
| 20-Day Relative Strength | 60.62 | 50.99 | 53.96 | ||
| Weighted Alpha | -77.75 | +181.10 | -19.37 | ||
| Today's Opinion | 72% Buy | 56% Buy | 16% Buy | ||
| Previous Opinion | 56% Buy | 40% Buy | 16% Buy | ||
| Last Month's Opinion | 40% Buy | 80% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.85% since 12/18/25 | -1.14% since 12/18/25 | +9.29% since 12/18/25 | ||
| Low | 3.50 on 12/19/25 | 1.6250 on 12/23/25 | 3.19 on 12/19/25 | ||
| High | 4.55 on 12/24/25 | 1.7700 on 12/22/25 | 3.60 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +19.51% since 11/26/25 | +1.17% since 11/26/25 | +7.29% since 11/26/25 | ||
| Low | 3.05 on 12/03/25 | 1.5700 on 12/03/25 | 3.08 on 12/02/25 | ||
| High | 4.55 on 12/24/25 | 1.8200 on 12/18/25 | 3.65 on 12/11/25 | ||
| 3-Month | |||||
| %Chg | +25.72% since 09/26/25 | +1.17% since 09/26/25 | +8.28% since 09/26/25 | ||
| Low | 2.80 on 10/15/25 | 1.5300 on 11/07/25 | 2.81 on 11/21/25 | ||
| High | 4.55 on 12/24/25 | 2.0900 on 11/03/25 | 4.51 on 10/15/25 | ||
| 6-Month | |||||
| %Chg | +117.50% since 06/26/25 | +79.40% since 06/26/25 | +36.29% since 06/26/25 | ||
| Low | 1.35 on 08/11/25 | 0.8500 on 07/01/25 | 2.40 on 07/01/25 | ||
| High | 4.83 on 08/27/25 | 2.0900 on 11/03/25 | 4.51 on 10/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 386,472 | 386,951 | 379,859 | ||
| Shares Outstanding, K | 87,437 | 230,328 | 108,222 | ||
| Annual Sales | 2,560,000 | 9,500,000 | 0 | ||
| Annual Net Income | -37,450,000 | -18,610,000 | -258,750,000 | ||
| Last Quarter Sales | 1,770,000 | 3,680,000 | 0 | ||
| Last Quarter Net Income | -29,820,000 | -29,780,000 | -50,330,000 | ||
| 60-Month Beta | 0.42 | 1.78 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 11/05/25 | -0.13 on 11/06/25 | -0.45 on 11/06/25 | ||
| Latest Earnings Date | 03/24/26 | 03/09/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | 0.080 on 12/15/03 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||